• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Provident Financial Services

Provident Financial Services

Provident Financial Services Inc PFS

Last Price$19.62Day Change (%)3.70%
Open Price$19.17Day Change ($)0.70
Day Range18.98–19.7052-Week Range16.13–19.70

As of Fri 7/31/2015 5:43:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. FDA Approves Kyprolis® (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed Multiple Myeloma

    FDA Approves Kyprolis® (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed Multiple Myeloma

  2. Cavium Unveils 100 Gbps NITROX® V Security Processor Family

    Cavium Unveils 100 Gbps NITROX® V Security Processor Family

  3. Research and Markets: Key Pharma News Issue - Gilead will make further oncology deals in 2015

    Research and Markets: Key Pharma News Issue - Gilead will make further oncology deals in 2015

  4. In a Pivotal Study, Genentech’s Investigational Immunotherapy Atezolizumab Shrank Tumors in People With a Specific Type of Bladder Cancer

    In a Pivotal Study, Genentech’s Investigational Immunotherapy Atezolizumab Shrank Tumors in People With a Specific Type of Bladder Cancer

  5. Oncolytics Biotech® Inc. Collaborators Present Final Data from REO 017 Clinical Study in Pancreatic Cancer

    Oncolytics Biotech® Inc. Collaborators Present Final Data from REO 017 Clinical Study in Pancreatic Cancer

  6. New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer

    New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer

  7. NAPFA’s CFP-Only Stand: A Step in the Wrong Direction

    A curious move, at a curious time, for purportedly, a curious reason, that is also a slap in the face to CPAs with the PFS credential.

  8. Reasons for Optimism

    This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...

  9. Making 401(k)s Into Annuities

    This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...

  10. What’s Wrong With Indexes?

    To the extent that this content includes references to securities, those references do not constitute an offer or solicitation to buy, sell or hold such security. AdvisorShares is a sponsor of actively managed exchange-traded funds (ETFs) and holds positions in all of its ETFs. This document should ...

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.